Glycerin/kaolin/sodium fluoride

An LDH inhibitor (Kis = 5.46 and 15.06 &microM, for the A and B isoforms, respectively) that prevents proliferation of many different cancer cells by blocking glycolysis and ATP production.

An anti-cancer natural product that acts on a variety of cellular pathways activates caspases, inhibits anti-apoptotic proteins, alters expression of Bcl-2 and Bax acts as a potent, slow inhibitor of Kir2.1 channels inhibits the chymotrypsin

An anti-cancer natural product that acts on a variety of cellular pathways activates caspases, inhibits anti-apoptotic proteins, alters expression of Bcl-2 and Bax acts as a potent, slow inhibitor of Kir2.1 channels inhibits the chymotrypsin

An anti-cancer natural product that acts on a variety of cellular pathways activates caspases, inhibits anti-apoptotic proteins, alters expression of Bcl-2 and Bax acts as a potent, slow inhibitor of Kir2.1 channels inhibits the chymotrypsin

Formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase a component of lipid rafts serves as a glycolipid receptor for bacterial host response signaling.

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

Immunogen 17 amino acids near the carboxy terminus of human GATA3. Application Used as a blocking peptide in immunoblotting applications.

GEFITINIB RELATED COMPOUND B

GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ, respectively, showing more than 3000-fold selectivity for PKC as compared to EGFR, PDGFR and insulin receptor. A highly selective

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

A long-acting sulfonylurea that inhibits KATP channels in pancreatic &beta-cells (IC₅₀ = 3 nM), which leads to the release of insulin increases the activity of intracellular insulin receptors and prevents insulin receptor downregulation

Immunogen 18 amino acids near the center of human GLIPR1. Application Used as a blocking peptide in immunoblotting applications.